File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Dimethyl Sulfoxide enhances osteoblastic differentiation of murine pre-osteoblast cells

TitleDimethyl Sulfoxide enhances osteoblastic differentiation of murine pre-osteoblast cells
Authors
Issue Date2005
PublisherJohn Wiley & Sons, Inc.
Citation
The 27th Annual Meeting of the American Society for Bone and Mineral Research, Nashville, TN, 23-27 September 2005. In Journal of Bone and Mineral Research, 2005, v. 20 n. S1, Abstract no. M208 How to Cite?
AbstractDimethyl sulfoxide (DMSO) is the most effective solvent that mixes readily with most water-insoluble and water-soluble substances. Similar to retinoic acid, DMSO demonstrates diverse differentiation-inducing effects on many cell types, including leukemia cells, myoblasts and embryonic stem cells. Recently, it is demonstrated that the DMSO-induced differentiation of leukemia cells is mediated via the upregulation of the tumor suppressor PTEN, which leads to the decrease of Akt phosphorylation. Although DMSO serves as solvent for most ligand-receptor studies of bone formation, the effect of DMSO on bone formation remains obscure. In this study, the effect of DMSO on osteoblast differentiation and phenotype-specific gene expression was examined using murine preosteoblast MC3T3E1 clone 4 (MC) cells as model systems. At concentrations of 0.5--1%, DMSO enhanced the osteoblast differentiation of MC cells as demonstrated by Von Kossa staining. Using real-time RT-PCR, DMSO was shown to upregulate the expression of alkaline phosphatase and collagen type la. To examine if DMSO acted on specific stage, osteogenic medium was supplemented with 1% DMSO transiently during osteoblast differentiation of MC cells. It was observed that maximum bone nodule formation was resulted when DMSO was supplemented at day 0--5 when compared with control. Expression of osteoblast-specific transcription factors, Runx2 and osterix, was upregulated during the differentiation process. DMSO treatment at day 5--10 or 10--15 resulted in no significant increase in bone nodule formation, suggesting that DMSO affects mainly the differentiation process but not the maturation, nor matrix mineralization process of osteoblast differentiation. While the expression of activated p42/p44 MAP kinases (MAPK) was downregulated, blockage of activated MAPK further enhanced the DMSO-mediated osteoblast differentiation. These data demonstrate that DMSO enhances osteoblast differentiation of MC cells by affecting the differentiation process via the inhibition of MAPK pathway.
Persistent Identifierhttp://hdl.handle.net/10722/102450
ISSN

 

DC FieldValueLanguage
dc.contributor.authorCheung, WMWen_HK
dc.contributor.authorNg, WSen_HK
dc.contributor.authorKung, AWCen_HK
dc.date.accessioned2010-09-25T20:31:08Z-
dc.date.available2010-09-25T20:31:08Z-
dc.date.issued2005en_HK
dc.identifier.citationThe 27th Annual Meeting of the American Society for Bone and Mineral Research, Nashville, TN, 23-27 September 2005. In Journal of Bone and Mineral Research, 2005, v. 20 n. S1, Abstract no. M208-
dc.identifier.issn1523-4681-
dc.identifier.urihttp://hdl.handle.net/10722/102450-
dc.description.abstractDimethyl sulfoxide (DMSO) is the most effective solvent that mixes readily with most water-insoluble and water-soluble substances. Similar to retinoic acid, DMSO demonstrates diverse differentiation-inducing effects on many cell types, including leukemia cells, myoblasts and embryonic stem cells. Recently, it is demonstrated that the DMSO-induced differentiation of leukemia cells is mediated via the upregulation of the tumor suppressor PTEN, which leads to the decrease of Akt phosphorylation. Although DMSO serves as solvent for most ligand-receptor studies of bone formation, the effect of DMSO on bone formation remains obscure. In this study, the effect of DMSO on osteoblast differentiation and phenotype-specific gene expression was examined using murine preosteoblast MC3T3E1 clone 4 (MC) cells as model systems. At concentrations of 0.5--1%, DMSO enhanced the osteoblast differentiation of MC cells as demonstrated by Von Kossa staining. Using real-time RT-PCR, DMSO was shown to upregulate the expression of alkaline phosphatase and collagen type la. To examine if DMSO acted on specific stage, osteogenic medium was supplemented with 1% DMSO transiently during osteoblast differentiation of MC cells. It was observed that maximum bone nodule formation was resulted when DMSO was supplemented at day 0--5 when compared with control. Expression of osteoblast-specific transcription factors, Runx2 and osterix, was upregulated during the differentiation process. DMSO treatment at day 5--10 or 10--15 resulted in no significant increase in bone nodule formation, suggesting that DMSO affects mainly the differentiation process but not the maturation, nor matrix mineralization process of osteoblast differentiation. While the expression of activated p42/p44 MAP kinases (MAPK) was downregulated, blockage of activated MAPK further enhanced the DMSO-mediated osteoblast differentiation. These data demonstrate that DMSO enhances osteoblast differentiation of MC cells by affecting the differentiation process via the inhibition of MAPK pathway.-
dc.languageengen_HK
dc.publisherJohn Wiley & Sons, Inc.-
dc.relation.ispartofJournal of Bone and Mineral Researchen_HK
dc.titleDimethyl Sulfoxide enhances osteoblastic differentiation of murine pre-osteoblast cellsen_HK
dc.typeConference_Paperen_HK
dc.identifier.emailNg, WS: wilsonng@ust.hken_HK
dc.identifier.emailKung, AWC: awckung@hku.hken_HK
dc.identifier.authorityKung, AWC=rp00368en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1002/jbmr.5650201306-
dc.identifier.hkuros112007en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats